BBVA USA Bancshares’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
BBVA USA Bancshares's ELV Position: Q1 2021 in Review
BBVA USA Bancshares reduced its Elevance Health (ELV) stake by 21% in Q1 2021, selling an estimated $117K and leaving 1,398 shares worth $502K. The position accounts for 0.02% of the portfolio, ranked #400.
BBVA USA Bancshares first reported a position in ELV in Q2 2013 and has held it in 15 quarters since. The position peaked at $864K in Q3 2014. 1,212 funds tracked by Wall St. Rank hold ELV as of Q1 2021.
- BBVA USA Bancshares held 1,398 shares of Elevance Health worth $502K as of Q1 2021.
- BBVA USA Bancshares sold 363 Elevance Health shares in Q1 2021, an estimated $117K.
- Elevance Health made up 0.02% of BBVA USA Bancshares's portfolio in Q1 2021, its #400 holding.
- BBVA USA Bancshares first reported a position in Elevance Health in Q2 2013 and has held it in 15 quarters since.
- BBVA USA Bancshares's Elevance Health position peaked at $864K in Q3 2014.
- 1,212 funds tracked by Wall St. Rank held Elevance Health as of Q1 2021.
Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.